DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cytarabine (Cytarabine) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (42)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine disability. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 42   Next >>

Possible Cytarabine side effects in 17 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: 17 year old female, weighing 42.7 kg (93.9 pounds)

Reactions: Flushing, Oral Pain, Skin Exfoliation, Pain of Skin, Peripheral Sensory Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-09
    End date: 2012-07-14

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-09
    End date: 2012-07-17

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-09
    End date: 2012-07-17

Doxorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Start date: 2012-06-09
    End date: 2012-07-14



Possible Cytarabine side effects in male

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-17

Patient: male, weighing 68.0 kg (149.6 pounds)

Reactions: Dyspnoea, Vomiting, Nausea, Hyperreflexia, Encephalopathy, Extensor Plantar Response, Endophthalmitis, Lung Consolidation, Respiratory Failure, Emotional Disorder, CSF Pressure Increased, Reflexes Abnormal, Lethargy

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 3600 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25

Clofarabine
    Dosage: 18 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25

Amsacrine
    Dosage: 220 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-28

Other drugs received by patient: Valaciclovir



Possible Cytarabine side effects in 66 year old male

Reported by a physician from France on 2012-08-07

Patient: 66 year old male, weighing 82.0 kg (180.4 pounds)

Reactions: Stenotrophomonas Infection, Coma, Device Related Infection, Pyrexia, Hypernatraemia, Loss of Consciousness, Malaise, Meningeal Disorder, Oedema Peripheral, Eye Movement Disorder, Blood Creatinine Increased, Cough, Hyperphosphataemia, Pleurisy, Pancytopenia, General Physical Health Deterioration, Aplasia, Convulsion, Nephrogenic Diabetes Insipidus, Neutropenia, Citrobacter Infection, Generalised Oedema, Hyperuricaemia, Myalgia, Weight Increased, Pleural Effusion, Crepitations, Thrombocytopenia, Jugular Vein Thrombosis, Candidiasis, Renal Failure Acute, Dyspnoea, Mucosal Inflammation, Diarrhoea, Monoparesis, Inflammation

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Treanda
    Dosage: 180 mg/m2 daily; 358.5 mg on day 1 + 2 of each cycle
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-02-27
    End date: 2012-02-28

Melphalan Hydrochloride
    Dosage: 250 mg total dose
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-03-03

Cytarabine
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-02-28
    End date: 2012-03-02

Etoposide
    Dosage: 400 mg/m2 daily; uid/qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-02-28
    End date: 2012-03-02

Treanda
    Indication: non-Hodgkin's Lymphoma



Possible Cytarabine side effects in 65 year old male

Reported by a physician from France on 2012-08-06

Patient: 65 year old male, weighing 74.0 kg (162.8 pounds)

Reactions: Oedema Peripheral, Pancytopenia, Blood Creatinine Increased, Generalised Oedema, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Treanda
    Dosage: 200 mg/kg daily; day 1 and 2 of each cycle
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-03-05

Etoposide
    Dosage: 380 mg from day 2 to day 5
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-03-06

Rituximab
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-03-06

Cytarabine
    Dosage: continuous infusion w/syringe driver 775 mg/day-day 2 to 5
    Indication: Bone Marrow Conditioning Regimen

Other drugs received by patient: Melphalan Hydrochloride



Possible Cytarabine side effects in 17 year old female

Reported by a physician from United States on 2012-08-03

Patient: 17 year old female, weighing 42.7 kg (93.9 pounds)

Reactions: Flushing, Skin Exfoliation, Oral Pain, Pain of Skin, Peripheral Sensory Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-09
    End date: 2012-07-14

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-09
    End date: 2012-07-17

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-09
    End date: 2012-07-14

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-09
    End date: 2012-07-17

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Myeloid Leukaemia



Possible Cytarabine side effects in 68 year old male

Reported by a physician from Italy on 2012-07-18

Patient: 68 year old male

Reactions: Tumour Lysis Syndrome, Renal Failure, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Sinus Tachycardia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-01

Idarubicin Hydrochloride
    Dosage: 24 mg, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: Levofloxacin; Allopurinol; Allopurinol; Normase; Mycostatin; Allopurinol; Zofran; Lasix



Possible Cytarabine side effects in female

Reported by a physician from Switzerland on 2012-07-13

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Electrocardiogram QT Prolonged

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Amsacrine
    Dosage: 185 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-27
    End date: 2012-06-27

Cytarabine
    Dosage: 1540 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-26
    End date: 2012-06-27

Clofarabine
    Dosage: 15.4 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-26
    End date: 2012-06-26

Amsacrine
    Dosage: 185 mg, unk
    Start date: 2012-06-27

Other drugs received by patient: Lorazepam; Methylprednisolone; Allopurinol; Ondansetron HCL; Ranitidine



Possible Cytarabine side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-25

Patient: 72 year old male

Reactions: Blood Urine Present, Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Febrile Bone Marrow Aplasia, Sinus Tachycardia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Idarubicin Hydrochloride
    Dosage: 24 mg, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Cytarabine
    Dosage: 200 mg milligram(s) intravenous (not otherwise specified)
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-01

Other drugs received by patient: Lasix; Mycostatin; (Normase); Allopurinol; Zofran; Levofloxacin



Possible Cytarabine side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-14

Patient: 72 year old male

Reactions: Blood Urine Present, Tachycardia, Pericardial Effusion, Haemoglobin Decreased, Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Febrile Bone Marrow Aplasia, Pleural Effusion

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg milligram(s), intravenous (not otherwise specified)
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-01

Idarubicin Hydrochloride
    Dosage: 24 mg, cyclic, intravenous (not otherwise specified)
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: (Normase); Mycostatin; Levofloxacin; Zofran; Allopurinol; Lasix



Possible Cytarabine side effects in 68 year old male

Reported by a physician from Italy on 2012-06-14

Patient: 68 year old male

Reactions: Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Sinus Tachycardia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Idarubicin Hydrochloride
    Dosage: 24 mg, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Cytarabine
    Dosage: 200 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-01

Other drugs received by patient: Lasix; Normase; Allopurinol; Zofran; Allopurinol; Levofloxacin; Mycostatin; Allopurinol



Possible Cytarabine side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-11

Patient: 72 year old male

Reactions: Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Pleural Effusion, Troponin Increased, Sinus Tachycardia, Pericardial Effusion

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg milligram(s), intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-01

Idarubicin Hydrochloride
    Dosage: 24 mg, cyclic, intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: Normase; Levofloxacin; Allopurinol; Mycostatin; Lasix; Zofran



Possible Cytarabine side effects in 47 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-04

Patient: 47 year old female

Reactions: Cerebellar Syndrome

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 3000 mg/m2, 2x/day, consolidation
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-18
    End date: 2012-04-22

Vancomycin
    Dosage: 1.5 g, 1x/day
    Start date: 2012-04-19

Other drugs received by patient: Pantoprazole; Piperacillin / Tazobactam Kabi; Neupogen; Chlormadinone Acetate TAB; Vfend; MAG 2



Possible Cytarabine side effects in 68 year old male

Reported by a physician from Italy on 2012-06-04

Patient: 68 year old male

Reactions: Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Sinus Tachycardia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-01

Idarubicin Hydrochloride
    Dosage: 24 mg, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: Levofloxacin; Lasix; Allopurinol; Normase; Zofran; Allopurinol; Allopurinol; Mycostatin



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-05-25

Patient: female

Reactions: Lung Consolidation, Osteonecrosis, Joint Range of Motion Decreased, Arthralgia, Limb Asymmetry, Gait Disturbance

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: intrathecal
    Indication: Acute Lymphocytic Leukaemia

Daunorubicin HCL
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Mercaptopurine
    Indication: Acute Lymphocytic Leukaemia

Vincristine Sulfate
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: intrathecal
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: intrathecal
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Indication: Acute Lymphocytic Leukaemia

Thioguanine
    Indication: Acute Lymphocytic Leukaemia



Possible Cytarabine side effects in 68 year old male

Reported by a physician from Italy on 2012-05-10

Patient: 68 year old male

Reactions: Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Sinus Tachycardia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-01

Idarubicin Hydrochloride
    Dosage: 24 mg, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: Allopurinol; Allopurinol; Zofran; Allopurinol; Normase; Levofloxacin; Lasix; Mycostatin



Possible Cytarabine side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-07

Patient: 72 year old male

Reactions: Tumour Lysis Syndrome, Renal Failure, Respiratory Failure, Pleural Effusion, Febrile Bone Marrow Aplasia, Sinus Tachycardia, Pericardial Effusion

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg milligram(s), intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-01

Idarubicin Hydrochloride
    Dosage: 24 mg, cyclic intravenous (not otherwise specified)
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: Levofloxacin; (Mycosatatin); (Normase); Zofran; Lasix; Allopurinol



Possible Cytarabine side effects in 68 year old male

Reported by a physician from Italy on 2012-05-03

Patient: 68 year old male

Reactions: Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Sinus Tachycardia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-01

Idarubicin Hydrochloride
    Dosage: 24 mg, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: Mycostatin; Allopurinol; Levofloxacin; Normase; Lasix; Allopurinol; Allopurinol; Zofran



Possible Cytarabine side effects in female

Reported by a physician from United Kingdom on 2012-05-03

Patient: female

Reactions: Eye Infection Toxoplasmal, Neutropenia, Uveitis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Etoposide
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-09
    End date: 2011-11-29

Cytarabine
    Dosage: unk
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-09
    End date: 2011-11-29

Everolimus
    Dosage: unk
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-09
    End date: 2011-11-29

Daunorubicin Hydrochloride
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-09
    End date: 2011-11-29

Other drugs received by patient: Ondansetron; Codeine; Vancomycin; Bisacodyl; Fluconazole; Docusate Sodium; Citalopram; Citalopram; Cyclizine; Phosphate-Sandoz; Metamucil-2; Zopiclone; Posaconazole; Nilstat; Pyrimethamine TAB; Acyclovir; Slow-K; Granulocyte Colony Stimulating Factor; Sulphadiazine; Scopolamine



Possible Cytarabine side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-24

Patient:

Reactions: Neurotoxicity

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Mantle Cell Lymphoma

Etoposide
    Indication: Mantle Cell Lymphoma

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Tositumomab-Iodine 131
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Mantle Cell Lymphoma

Cytarabine
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Indication: Mantle Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine
    Indication: Diffuse Large B-Cell Lymphoma

Tositumomab-Iodine 131
    Indication: Mantle Cell Lymphoma



Possible Cytarabine side effects in female

Reported by a physician from United Kingdom on 2012-03-29

Patient: female

Reactions: Eye Infection Toxoplasmal, Uveitis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-05-09
    End date: 2011-11-29

Etoposide
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-05-09
    End date: 2011-11-29

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-05-09
    End date: 2011-11-29

Everolimus
    Dosage: unk
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-05-09
    End date: 2011-11-29

Other drugs received by patient: Nilstat; Slow-K; Ondansetron; Voriconazole; Vancomycin; Phosphate-Sandoz; Cyclizine; Scopolamine; Citalopram Hydrobromide; Fluconazole; Neupogen; Acyclovir; Codeine Sulfate; Zopiclone



Possible Cytarabine side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-29

Patient: 51 year old female, weighing 29.9 kg (65.9 pounds)

Reactions: Myalgia, Neuropathy Peripheral, Mobility Decreased, Paraesthesia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 186 mg milligram(s), intravenous, 175 mg milligram(s), intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-09
    End date: 2011-11-09

Cytarabine
    Dosage: 186 mg milligram(s), intravenous, 175 mg milligram(s), intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-12-29
    End date: 2011-12-29

Other drugs received by patient: Acyclovir; (Zopiclone); Gabapentin; Ondansetron; Allopurinol; Daunorubicin HCL; Estradiol; Lorazepam; Midodrine Hydrochloride; Acetaminophen; Thiamine HCL; Lansoprazole; Pregabalin; Itraconazole; Fludrocortisone Acetate; Metoclopramide; (Sando K / 00031402 / ); (Vitamin B Compound / 00212701 / )



Possible Cytarabine side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-26

Patient: 71 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Multi-Organ Failure, Cytotoxic Cardiomyopathy

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Vidaza
    Dosage: 135 milligram
    Start date: 2011-01-11
    End date: 2011-01-15

Daunorubicin HCL
    Dosage: 112 milligram
    Start date: 2011-02-11
    End date: 2011-02-13

Daunorubicin HCL
    Dosage: 60 milligram/sq. meter
    Start date: 2011-04-13
    End date: 2011-04-15

Cytarabine
    Start date: 2011-01-16
    End date: 2011-01-22

Cytarabine
    Dosage: 186 milligram
    Start date: 2011-02-09
    End date: 2011-02-15

Daunorubicin HCL
    Dosage: 112 milligram
    Start date: 2011-01-18
    End date: 2011-01-20

Vidaza
    Dosage: 135 milligram
    Start date: 2011-02-04
    End date: 2011-02-08

Vidaza
    Dosage: 135 milligram
    Start date: 2011-04-06
    End date: 2011-04-10

Cytarabine
    Dosage: 36 gram
    Start date: 2011-04-11
    End date: 2011-04-26

Other drugs received by patient: Tazobactam; Tazobactam; Meropenem; Tazobactam; Vancomycin; Meropenem; Vancomycin



Possible Cytarabine side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-21

Patient: 71 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Multi-Organ Failure, Cytotoxic Cardiomyopathy

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 36 gram
    Start date: 2011-04-11
    End date: 2011-04-26

Vidaza
    Dosage: 135 milligram
    Start date: 2011-02-04
    End date: 2011-02-08

Vidaza
    Dosage: 135 milligram
    Start date: 2011-01-11
    End date: 2011-01-15

Daunorubicin HCL
    Dosage: 60 milligram/sq. meter
    Start date: 2011-04-13
    End date: 2011-04-15

Vidaza
    Dosage: 135 milligram
    Start date: 2011-04-06
    End date: 2011-04-10

Daunorubicin HCL
    Dosage: 112 milligram
    Start date: 2011-01-18
    End date: 2011-01-20

Cytarabine
    Dosage: 186 milligram
    Start date: 2011-02-09
    End date: 2011-02-15

Daunorubicin HCL
    Dosage: 112 milligram
    Start date: 2011-02-11
    End date: 2011-02-13

Cytarabine
    Start date: 2011-01-16
    End date: 2011-01-22

Other drugs received by patient: Tazobactam; Tazobactam; Vancomycin; Meropenem; Meropenem; Tazobactam; Vancomycin



Possible Cytarabine side effects in 39 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-20

Patient: 39 year old male

Reactions: Facial Paresis, Deafness Bilateral, Visual Acuity Reduced, Hemiparesis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 2000 mg/m2, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2010-12-23
    End date: 2011-05-06

Cisplatin
    Dosage: 100 mg/m2, monthly
    Indication: non-Hodgkin's Lymphoma
    Start date: 2010-12-23
    End date: 2011-05-04

Other drugs received by patient: Oxaliplatin; Dexamethasone



Possible Cytarabine side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-12

Patient: female

Reactions: Neurotoxicity, Cytogenetic Abnormality, Nervous System Disorder, Dizziness, Ataxia, Fluid Retention

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gleevec
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-10-11
    End date: 2010-12-23

Cytarabine

Gleevec
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Chromosome Analysis Abnormal
    Start date: 2010-11-08

Gleevec
    Dosage: 300 mg, qd
    Administration route: Oral

Other drugs received by patient: Methotrexate; Chemotherapeutics NOS; Zofran; Flexium



Possible Cytarabine side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-03-12

Patient: male, weighing 15.0 kg (33.0 pounds)

Reactions: Tachycardia, Deafness, Encephalitis, Pyrexia, Poor Quality Sleep, Hypokinesia, Balance Disorder, Leukoencephalopathy, Hypotension, Abnormal Behaviour, General Physical Health Deterioration, Ataxia, Anxiety, Limb Discomfort, Neoplasm Malignant, Tendon Disorder, Disturbance in Attention, Stenotrophomonas Sepsis, Gait Disturbance, Asthenia

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Methotrexate
    Indication: Acute Myeloid Leukaemia
    Start date: 2009-12-02
    End date: 2010-05-26

Cytarabine
    Indication: Acute Myeloid Leukaemia
    Start date: 2009-12-05
    End date: 2010-05-27

Other drugs received by patient: Etopophos Preservative Free



Possible Cytarabine side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-28

Patient: 51 year old female, weighing 29.9 kg (65.9 pounds)

Reactions: Myalgia, Neuropathy Peripheral, Paraesthesia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-09
    End date: 2011-11-09

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-12-29
    End date: 2011-12-29

Other drugs received by patient: Midodrine Hydrochloride; Pregabalin; Lansoprazole; Metoclopramide; (Vitamin B Compound / 00212701 / ); (Elleste Duct); Fludrocortisone Acetate; Itraconazole; Acyclovir; Gabapentin; Daunorubicin HCL; Acetaminophen; (Zoplicone); Allopurinol; Ondansetron; (Sando K / 00031402 / ); Lorazepam; Thiamine HCL



Possible Cytarabine side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-24

Patient: 51 year old female, weighing 66.0 kg (145.2 pounds)

Reactions: Myalgia, Neuropathy Peripheral, Paraesthesia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 186 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-09
    End date: 2011-11-09

Cytarabine
    Dosage: 175 mg, unk
    Start date: 2011-12-29
    End date: 2011-12-29

Other drugs received by patient: Fludrocortisone; Estradiol; Itraconazole; Pregabalin; Gabapentin; Zopiclone; Sando K; Vitamin B 1-6-12; Metoclopramide; Thiamine; Ondansetron; Paracetamol; Aciclovir; Lansoprazole; Lorazepam; Allopurinol; Daunorubicin; Midodrine



Possible Cytarabine side effects in female

Reported by a physician from France on 2012-02-17

Patient: female, weighing 47.0 kg (103.4 pounds)

Reactions: Acute Myeloid Leukaemia, Bone Marrow Failure, Necrotising Fasciitis, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1450 mg, qdx5
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-06-28
    End date: 2010-07-02

Evoltra
    Dosage: 43.5 mg, qdx5
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-06-29
    End date: 2010-07-03

Other drugs received by patient: Imipenem and Cilastatin Sodium; Acupan; Lexomil; Zovirax; Neupogen; Amikacin; Fluconazole; Vancomycin



Possible Cytarabine side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-02-03

Patient: 71 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Multi-Organ Failure, Cytotoxic Cardiomyopathy

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Cytarabine
    Dosage: 186 milligram
    Start date: 2011-02-09
    End date: 2011-02-15

Daunorubicin HCL
    Dosage: 112 milligram
    Start date: 2011-01-18
    End date: 2011-01-20

Daunorubicin HCL
    Dosage: 112 milligram
    Start date: 2011-02-11
    End date: 2011-02-13

Vidaza
    Dosage: 140 milligram
    Start date: 2011-02-04
    End date: 2011-02-08

Vidaza
    Dosage: 135 milligram
    Start date: 2011-04-06
    End date: 2011-04-10

Vidaza
    Dosage: 135 milligram
    Start date: 2011-01-11
    End date: 2011-01-15

Cytarabine
    Start date: 2011-01-16
    End date: 2011-01-22

Cytarabine
    Dosage: 36 gram
    Start date: 2011-04-11

Other drugs received by patient: Tazobactam; Vancomycin; Meropenem; Vancomycin; Tazobactam; Tazobactam; Meropenem



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014